Clinical Trials
4
Active:0
Completed:2
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Vision Improvement for Legally Blind Dry AMD Patients
Not yet recruiting
- Conditions
- Vision Impairment and BlindnessDry Age-related Macular Degeneration
- First Posted Date
- 2021-05-06
- Last Posted Date
- 2023-03-22
- Lead Sponsor
- Optimal Acuity Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT04875234
Observational Study of Vision Improvement in Patients With Retinal Disorders
Completed
- Conditions
- Age-related Macular DegenerationDiabetic Macular Edema
- First Posted Date
- 2021-01-05
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Optimal Acuity Corporation
- Target Recruit Count
- 54
- Registration Number
- NCT04693702
- Locations
- 🇨🇦
Bochner Eye Institute, Toronto, Ontario, Canada
Observational Study of Vision Improvement in Late Stage Dry AMD Patients
Completed
- Conditions
- Dry Age-related Macular Degeneration
- First Posted Date
- 2020-04-16
- Last Posted Date
- 2021-02-24
- Lead Sponsor
- Optimal Acuity Corporation
- Target Recruit Count
- 17
- Registration Number
- NCT04349254
- Locations
- 🇨🇦
Bochner Eye Institute, Toronto, Ontario, Canada
Vision Improvement for Patients With Age-Related Macular Degeneration
Not Applicable
Not yet recruiting
- Conditions
- Age-related Macular Degeneration
- First Posted Date
- 2020-02-13
- Last Posted Date
- 2023-03-22
- Lead Sponsor
- Optimal Acuity Corporation
- Target Recruit Count
- 200
- Registration Number
- NCT04268836
- Locations
- 🇨🇦
1929 Bayview Ave., Suite 117, Toronto, Ontario, Canada
News
No news found